Download full-text PDF

Source

Publication Analysis

Top Keywords

[ketamine geriatrics]
4
[ketamine
1

Similar Publications

Purpose: The routine perioperative use of opioids has recently been questioned due to opioid-related side effects, which can be potentially harmful in geriatric patients. This study aimed to evaluate the effects of opioid-free anesthesia in geriatric patients undergoing hip surgery.

Patients And Methods: A total of 121 patients, aged 60 years or older, undergoing elective hip surgery were randomized to receive either opioid-free anesthesia with dexmedetomidine and esketamine (OFA group) or balanced anesthesia with opioids (CON group).

View Article and Find Full Text PDF

Response to comment on "High- versus low-dose ketamine for analgesia in older adults in the emergency department".

Am J Emerg Med

November 2024

Department of Emergency Medicine, Mayo Clinic, Rochester, MN, USA; Department of Medicine, Division of Community Internal Medicine, Geriatric Medicine and Palliative Care, Mayo Clinic, Rochester, MN, USA; Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.

View Article and Find Full Text PDF

High- versus low-dose ketamine for analgesia in older adults in the emergency department.

Am J Emerg Med

December 2024

Department of Emergency Medicine, Mayo Clinic, Rochester, MN, USA; Department of Medicine, Division of Community Internal Medicine, Geriatric Medicine and Palliative Care, Mayo Clinic, Rochester, MN, USA; Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.

Background And Objectives: Ketamine is increasingly being utilized in the management of acute pain in the emergency department (ED), including for older adults, a population at increased risk of adverse effects from medications. We aimed to compare the safety and analgesic effects of high-dose (≥0.3mg/kg) to low-dose (<0.

View Article and Find Full Text PDF
Article Synopsis
  • Esketamine (ESK) is an intravenous anesthetic known to have antidepressant effects, but the exact mechanism behind this is not well understood.
  • The study investigated the involvement of microglial cannabinoid type 2 (CB2) receptors and protein kinase C (PKC) in ESK's antidepressant action, using lipopolysaccharide (LPS) to induce neuroinflammation in microglial cells.
  • Results showed that ESK reduced inflammation by lowering proinflammatory cytokines and nitrite levels, and that this effect was blocked when using a CB2 receptor antagonist or PKC inhibitor, indicating that the CB2-PKC pathway plays a key role in ESK's anti-inflammatory effects.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!